Article Versions Notes

Abahssain H, Pasquier D, Laabid K, Barani M, Borges S, Poitureau S, Bettache G, Nguyen T-L-A, Bytha M, Rodriguez J, et al. Modern Management of the Axilla in HER2-Negative Hormone Receptor-Positive Early Breast Cancer Upfront Surgery: Toward De-Escalation and Individualization. Cancers. 2026; 18(1):131. https://doi.org/10.3390/cancers18010131

Abahssain, Halima, David Pasquier, Khaoula Laabid, Meryem Barani, Sébastien Borges, Stephen Poitureau, Ghizlane Bettache, Thi-Lan-Anh Nguyen, Mbolam Bytha, Joseph Rodriguez, and et al. 2026. "Modern Management of the Axilla in HER2-Negative Hormone Receptor-Positive Early Breast Cancer Upfront Surgery: Toward De-Escalation and Individualization" Cancers 18, no. 1: 131. https://doi.org/10.3390/cancers18010131

Abahssain, H., Pasquier, D., Laabid, K., Barani, M., Borges, S., Poitureau, S., Bettache, G., Nguyen, T.-L.-A., Bytha, M., Rodriguez, J., Lemaire, A., Curigliano, G., & Souadka, A. (2026). Modern Management of the Axilla in HER2-Negative Hormone Receptor-Positive Early Breast Cancer Upfront Surgery: Toward De-Escalation and Individualization. Cancers, 18(1), 131. https://doi.org/10.3390/cancers18010131